Woodline Partners logo

Woodline Partners

North America, California, United States, San Francisco

Description

Woodline Partners is a private equity firm that focuses on the healthcare and technology sectors.

Investor Profile

Woodline Partners has made 60 investments, with 13 in the past 12 months and 7% as lead.

Stage Focus

  • Post Ipo Equity (47%)
  • Series B (23%)
  • Series C (12%)
  • Series A (7%)
  • Series D (5%)
  • Series F (3%)
  • Private Equity (2%)
  • Series Unknown (2%)

Country Focus

  • United States (87%)
  • United Kingdom (5%)
  • Germany (3%)
  • Canada (2%)
  • Japan (2%)
  • Sweden (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Life Science
  • Biopharma
  • Oncology
  • Precision Medicine
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Woodline Partners frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 12
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 12
Casdin Capital
North America, New York, United States, New York
Co-Investments: 10
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 14
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 11
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 10
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 17
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 15
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 10
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 9

Which angels does Woodline Partners often collaborate with?

DL
Europe, East Sussex, United Kingdom, Eastbourne
Shared Deals: 1
BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
AK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Woodline Partners?

Archive

Los Altos, California, United States

Archive is a technology company that builds innovative, scalable, and profitable resale businesses for global brands.

FashionMarketplaceRetail
Series BFeb 4, 2025
Amount Raised: $30,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityFeb 3, 2025
Amount Raised: $185,000,000
Kala Pharmaceuticals

Waltham, Massachusetts, United States

Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityDec 30, 2024
Amount Raised: $10,750,000
Olema Oncology

San Francisco, California, United States

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceutical
Post Ipo EquityDec 2, 2024
Amount Raised: $250,000,000
Blue Earth Therapeutics

Oxford, Oxfordshire, United Kingdom

Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.

Health CareMedicalPharmaceuticalTherapeutics
Series AOct 30, 2024
Amount Raised: $76,500,000
Eledon Pharmaceuticals

Irvine, California, United States

Eledon Pharmaceuticals is a biotechnology company developing treatments for people undergoing organ or cellular transplantation.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityOct 29, 2024
Amount Raised: $85,000,000
Formo

Berlin, Berlin, Germany

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

BiotechnologyFood and BeverageLife Science
Series BSep 9, 2024
Amount Raised: $61,000,000
OrsoBio

Palo Alto, California, United States

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series BSep 6, 2024
Amount Raised: $67,000,000
Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
AnaptysBio

San Diego, California, United States

AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 14, 2024
Amount Raised: $100,000,000